Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Assessment of Response to Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT

NCT04271436 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT04271436
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04271436 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Assessment of Response to Immune Checkpoint Blockade Therapy Using 18F-FLT PET/CT
Lead sponsor
Washington University School of Medicine
Phase
Phase 2
Overall status
Withdrawn
Start date
April 22, 2021
Completion date
January 31, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cancer